Varian ProBeam Proton Therapy System Clinical Trial (Shandong)

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

July 20, 2022

Primary Completion Date

March 8, 2023

Study Completion Date

March 10, 2023

Conditions
Tumor, Solid
Interventions
DEVICE

Radiation: Proton Therapy System (ProBeam)

"All enrolled subjects will be treated with Proton radiation therapy using the medical device Varian Proton Therapy System (ProBeam). The screening period from informed consent to enrollment is expected to be 2 weeks, while the treatment period depends on patient medical situation and treatment plan. The period after the last treatment is divided into short-term follow-up which is 90 days after treatment completion and long-term follow-up which is 5 years after treatment completion. The clinical trial with short-term follow-up fulfills the requirements for NMPA regulatory registration. All the end points claimed will be achieved in the short-term follow-up stage. The trial is defined as completion once short-term follow-up is finished.~And long-term follow-up report will be submitted for future post market evaluation when requested by NMPA."

Trial Locations (1)

230001

Sophia Shao, Shanghai

All Listed Sponsors
lead

Varian, a Siemens Healthineers Company

INDUSTRY